🔎 Trials Near Me

Home › Overactive Bladder › NCT07195656

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB)

Recruiting

Evaluation of a Non-Implanted Electrical Stimulation Device for Overactive Bladder (OAB) EVANESCE-II

Who can join

Ages 21 and older · Women

Full eligibility criteria
Key Inclusion Criteria:

* Females, defined as a person with a uterus and cervix, ≥21 years old, with a diagnosis of OAB and symptoms for more than 6 months, as confirmed by a physician. OAB is defined by urinary urgency, usually with urinary frequency and nocturia, with or without urgency urinary incontinence with symptoms
* Willing and able to comply with study required procedures and visits (e.g., maintaining consistent medication use, fluid intake, diary completion).

Key Exclusion Criteria:

* Systemic condition or disease that may interfere with study participation (e.g., current systemic infection, uncontrolled autoimmune disease, uncontrolled immunodeficiency disease, history of myocardial infarction, etc.) as determined by study investigator.
* Not an appropriate study candidate as determined by investigator.

About the study

A study to evaluate the safety and effectiveness of FemPulse System

What is being tested

Sponsor: FemPulse Corporation · Participants: 151 · Started: Sep 30, 2025

Contact the study team

Official record on ClinicalTrials.gov — NCT07195656

Locations in the U.S.

CaliforniaCedars Sinai, Beverly Hills
UCLA, Los Angeles
UC Irvine, Orange
Stanford, Palo Alto
USCD, San Diego
FloridaHoly Cross Medical Group - Women's Center, Fort Lauderdale
IllinoisComprehensive Urologic, Barrington
KentuckyUniversity of Louisville, Louisville (Not yet recruiting)
MarylandChesapeake Urology, Owings Mills
MinnesotaMinnesota Urology, Woodbury (Not yet recruiting)
NebraskaAdult & Pediatric Urology, Omaha
North CarolinaAtrium Health, Charlotte
South CarolinaSouthern Urogynecology, West Columbia
South DakotaSanford Health, Sioux Falls
VirginiaINOVA, Falls Church (Not yet recruiting)

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.